Quantifying individual nociceptive sensitivity to optimise analgesic trials in infants

Despite the high burden of pain experienced by hospitalised infants there are few analgesics with proven efficacy. Testing analgesics in infants is experimentally and ethically challenging and minimising the number of infants required to demonstrate efficacy is essential. EEG-derived measures of noxious-evoked brain activity can be used to assess analgesic efficacy, however, as variability exists in infant's responses to painful procedures, large sample sizes are often required. Here we present a novel experimental paradigm to account for individual differences in baseline nociceptive sensitivity which can be used to improve the design of analgesic trials in infants. The paradigm is developed and tested across four studies using clinical, experimental and simulated data (99 infants). We provide evidence of the efficacy of both gentle brushing and paracetamol, substantiating the need for randomised controlled trials of these interventions. This work provides an important step towards safe, cost-effective clinical trials of analgesics in infants.

Introduction trials is to stratify infants across treatment arms, and to adjust for these factors in the 72 statistical analysis (McEntegart, 2003). While this can improve comparability across 73 groups for recognised factors, many unknown variables likely influence pain sensitivity 74 and a more nuanced approach to account for individual differences in nociceptive 75 sensitivity could be more effective in reducing sample sizes. In analgesic studies performed 76 in adults, individual pain thresholds can be identified by applying graded increments of 77 experimental stimulus intensity until pain is reported by the participants. This can be used 78 neonatal studies of analgesic efficacy. In Study 1, we demonstrate that the magnitude of 96 noxious-evoked brain activity in response to an experimental stimulus correlates with the 97 magnitude of brain activity evoked by the clinical procedure and thus reflects baseline 98 nociceptive sensitivity. In Study 2, we use simulated data to demonstrate the increased 99 statistical power that can be achieved by including baseline nociceptive sensitivity as a 100 covariate when analysing the effect of an intervention in small samples. In Study 3, we test 101 this novel paradigm using a non-pharmacological pain-relieving intervention of known 102 efficacy -gentle touch -prior to heel lancing. Finally, in Study 4 we investigated the 103 analgesic efficacy of oral paracetamol given prior to immunisation in prematurely-born 104 infants. Overall, we demonstrate that measuring and accounting for baseline nociceptive 105 sensitivity could improve the design of analgesic efficacy investigations for this patient 106 population. 107 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint could provide a novel measure of infant baseline nociceptive sensitivity, which could be 131 used as a covariate in studies of analgesic efficacy to account for inter-individual variability 132 in pain responses (Figure 1). In the following sections, we simulate and test the impact of 133 applying this novel paradigm in studies investigating the efficacy of pain-relieving 134 interventions. 135

137
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint Study 2: Simulating the effect of accounting for individual nociceptive sensitivity 138 139 In Study 2, we used simulated data to investigate whether accounting for individual 140 differences in baseline nociceptive sensitivity has the potential to reduce the sample size 141 needed to assess the efficacy of an analgesic intervention. Here we initially assume that an 142 effective analgesic intervention results in a 40% reduction in noxious-evoked brain 143 activity; this is clinically meaningful as a similar reduction in noxious-evoked brain activity 144 is observed when adults report significantly lower verbal pain scores (Lorenz et al. Methods). At a significance level of 0.05, the sample size to achieve a given power is 153 substantially reduced when nociceptive sensitivity is accounted for ( Figure 2B). The 154 reduction in sample size that can be achieved by accounting for individual differences in 155 nociceptive sensitivity is highly dependent on the anticipated effect size of the intervention 156 ( Figure 2C, D). For example, at the extremes we considered, with an assumed intervention 95% power is 5458 infants per group without accounting for individual nociceptive 162 sensitivity, compared with 660 infants per group when nociceptive sensitivity is accounted 163 for -representing an 88% reduction in sample size ( Figure 2C, D). Assuming an 164 intervention effect size of 40%, a sample size of 16 infants per group (32 infants in total) 165 would be sufficient to observe a significant intervention effect with 95% power if 166 individual differences in nociceptive sensitivity are accounted for. In contrast, a sample 167 size of 66 infants per group (132 infants in total) is required to achieve the same power if 168 infant nociceptive sensitivity is not accounted for ( Figure 2B).  Study 3: Testing the paradigm: a non-pharmacological pain-relieving intervention study  204   205 In a previous study, we reported that a non-pharmacological gentle touch intervention, 206 (brushing an infant's leg at a rate of approximately 3cm/s to optimally stimulate C-tactile 207 fibres) prior to a clinically-required heel lance caused a 40% reduction in noxious-evoked 208 brain activity (Gursul et al., 2018). In Study 3, we used the same non-pharmacological 209 intervention in an independent prospective cohort of healthy infants that clinically required 210 a heel lance for the purpose of blood sampling and tested the effect of incorporating the 211 nociceptive sensitivity paradigm and accounting for inter-individual differences in baseline 212 nociceptive sensitivity. Based on power calculations from simulated data in Study 2, 213 assuming a 40% reduction in noxious-evoked brain activity from the intervention and 95% 214 power, a total of 16 infants were included in the Intervention Group and were gently 215 brushed on the leg ipsilateral to the stimulus site at a rate of approximately 3cm/s for 10 216 seconds prior to heel lancing (Gursul et al., 2018). A further 15 infants were included in 217 the Control Group where the heel lance was performed without gentle brushing. All infants 218 received mild experimental noxious stimulation prior to heel lancing to assess their 219 individual baseline nociceptive sensitivity (see Methods). Unlike Study 1, in which infants 220 had been stimulated with a force of 64 mN, a force of 128mN was applied in this 221 prospective cohort to increase the signal-to-noise ratio. The necessary strong correlation 222 between the evoked response to the experimental stimulus and clinical procedure was 223 confirmed in the Control group (p=0.0013, R 2 =0.65, Figure 3A). 224 Consistent with the previously published study (Gursul et al., 2018), the gentle touch 225 intervention resulted in a 39% reduction in the magnitude of the noxious-evoked brain 226 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint activity, but a significant intervention effect was not observed (although the result indicated 227 borderline significance) when nociceptive sensitivity was not accounted for, likely due to 228 the lack of power with this sample size (linear regression, t=1.95, p=0.05, Figure 3B, Study 229 2 indicates a power of 40% for a sample of this size without accounting for nociceptive 230 sensitivity, Figure 2B). However, when baseline nociceptive sensitivity was accounted for 231 as a covariate in the analysis, a significant intervention effect was observed (linear 232 regression, t=2.29, p=0.026). 233 To further understand these results we compared the relationship between the responses 234 within the Control Group and Intervention Group. Unlike the significant correlation 235 between the magnitude of noxious-evoked brain activity in response to the experimental 236 noxious stimuli and heel lancing demonstrated in the Control group (p=0.0013, R 2 =0.65, 237 Figure 3A), this relationship was disrupted in the Intervention Group (p=0.39, R 2 =0.05, 238 Figure 3C). In particular, we observed reduced noxious-evoked brain activity following the 239 gentle brushing intervention in infants with high baseline nociceptive sensitivity ( Figure  240 3D), suggesting that the effect of pain-relieving interventions is most prominent in infants 241 with greater baseline nociceptive sensitivity. Each infant's EEG responses to the 242 experimental noxious stimulus and the heel lance are shown in Figure S1. 243 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint

258
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020.  Figure 4A). However, this correlation in reflex withdrawal activity was weaker 269 than the relationship in the noxious-evoked brain activity, limiting its use ( Figure 2E). 270 Assuming an intervention effect of 40% and this level of correlation identified within the 271 same size sample, simulated data reveals that accounting for nociceptive sensitivity using 272 reflex activity provides only 17.3% power to detect a significant difference between the 273 two groups compared with a power of 11.3% without accounting for nociceptive 274 sensitivity. 275

276
In this study, the gentle touch intervention did not significantly reduce the magnitude of 277 the reflex withdrawal activity following heel lancing, either when accounting for 278 nociceptive sensitivity (linear regression, t=-1.43, p=0.17,) or without accounting for 279 nociceptive sensitivity (t=-1.73, p=0.10, Figure 4B). While it is possible that reflex 280 withdrawal of the stimulated limb is not modulated by gentle touch, as has previously been 281 suggested (Gursul et al., 2018), the intervention clearly disrupted the correlation between 282 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

298
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint

Study 4: A pharmacological analgesic study 299 300
In Study 4, we conducted an opportunistic study to investigate whether the administration 301 of paracetamol prior to immunisation significantly reduces noxious-evoked brain activity. 302 In 2015, national clinical guidelines recommended the administration of paracetamol at the 303 time of Meningitis B immunisation due to its antipyretic effect (Public Health England and 304 NHS England, 2015). Therefore, our local neonatal unit (John Radcliffe Hospital) began 305 administering oral paracetamol to infants immediately after vaccination. In October 2018, 306 the local practice guidelines were updated, recommending the administration of oral 307 paracetamol one-hour pre-vaccination. Prior to the guideline change, we studied 17 infants 308 who did not receive paracetamol before immunisations (Control Group), recording their 309 noxious-evoked brain activity during immunisations. Following the guideline change, we 310 recorded noxious-evoked brain activity in 16 infants who received paracetamol one-hour 311 prior to immunisations (Intervention Group) (see Methods and Figure 5A). In the 312 Intervention Group we explored the relationship between baseline nociceptive sensitivity 313 and brain activity evoked by immunisation following paracetamol administration. were recorded on the same test occasion. First, we validated that the template of noxious-319 evoked brain activity  can be used to quantify the magnitude of 320 noxious-evoked brain activity from immunisation applied to the thigh (experimental data 321 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint presented in Supplementary Materials, Figure S3 and S4). The magnitude of noxious-322 evoked brain activity following immunisation was significantly lower in the infants who 323 range: -0.07 -2.14). Although we did not record the baseline sensitivity in infants in the 341 Control Group, in the absence of a pain-relieving intervention we would expect the 342 response to be correlated with noxious-evoked brain activity evoked by immunisation. As 343 the correlation between baseline sensitivity and response to immunisation was low in the 344 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint Intervention Group (p=0.12, R 2 =0.33, n=9, Figure 5C), the relationship between these 345 measures was likely disrupted by paracetamol. Similar to the gentle brush intervention, the 346 infants with high baseline nociceptive sensitivity, represented by a high magnitude 347 response to experimental noxious stimulation prior to paracetamol administration, had 348 much lower magnitude responses to immunisation than would have been expected without 349 an analgesic intervention ( Figure 5C). Similarly, the correlation between the baseline 350 nociceptive sensitivity (magnitude of the baseline nociceptive sensitivity prior to 351 paracetamol administration) and the response to the experimental noxious stimuli one-hour 352 post-paracetamol administration was disrupted (p=0.83, R 2 =0.006, n=9, Figure 5D). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint We demonstrate that accounting for individual differences in nociceptive sensitivity 381 significantly reduces the sample size required to assess the efficacy of analgesics in infants. 382 Noxious-evoked brain activity in response to a low-intensity experimental noxious 383 stimulus can be used in infants as a marker of baseline nociceptive sensitivity and is highly 384 correlated with the magnitude of noxious-evoked brain activity produced by clinically-385 required acute painful procedures. Using both simulated and experimental data, we 386 demonstrate that the sample size required to observe the effects of analgesic interventions 387 (for a given power and significance level) can be significantly reduced when nociceptive 388 sensitivity is accounted for. Importantly, the percentage reduction in sample size is related 389 to the expected effect size of the intervention and the degree of correlation between the 390 baseline nociceptive sensitivity measure and the brain activity evoked by the clinical 391 procedure. By testing this novel paradigm in clinical studies, we re-confirm the efficacy of 392 gentle touch as a non-pharmacological intervention that reduces brain activity evoked by 393 heel lancing (Gursul et al., 2018) and we provide evidence to suggest that oral paracetamol 394 is a candidate analgesic drug for procedural pain in infants. Although these studies have a 395 number of limitations (including lack of randomisation), and only investigate one aspect 396 of the infant response to nociceptive input (namely an EEG-derived noxious-evoked 397 potential), they provide strong evidence to suggest that randomised clinical trials 398 investigating the efficacy of both gentle touch and paracetamol through multimodal pain 399 assessment measures are warranted. 400 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. there is no evidence from our data that the experimental noxious stimuli increases the 419 magnitude of the heel lance response given that the responses to heel lance reported here 420 are similar to previous papers where the experimental noxious stimuli was not applied 421 , suggesting it is appropriate for use in a clinical setting. Despite the 422 advantage of using this approach, we cannot rule out the potential effects of selection bias 423 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint (Bishop, 2020). A relatively high number of trials were rejected due to artefacts, which 424 may be more pronounced when there are stimulus-related movements. If these movements 425 are indicative of a more vigorous response to the nociceptive input, then it is plausible that 426 we are unavoidably biased towards a subset of the population. In an independent population of infants, we re-confirmed that brushing 434 the skin prior to a clinically-required heel lance significantly reduces noxious-evoked brain 435 activity. We used our nociceptive sensitivity paradigm to indirectly account for many 436 factors that influence the magnitude of noxious-evoked brain activity. In addition, we did 437 not observe a significant difference in reflex withdrawal activity between the control 438 infants and the infants who received gentle touch prior to the heel lance, which is consistent 439 with our previous observations (Gursul et al., 2018). It is possible that either the magnitude 440 of the reflex withdrawal is genuinely not modulated by the brush intervention or that a 441 modulation in reflex activity would only be observed with a larger sample size. 442 Importantly, a significant but weak correlation was observed between the reflex activity in 443 response to the noxious stimuli and in response to heel lancing in the Control Group, 444 suggesting that the paradigm presented here could be useful in future trials where reflex 445 withdrawal activity is used as an outcome measure. 446 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint

447
In addition to minimising sample sizes, assessing baseline nociceptive sensitivity may also 448 allow for identification of infants that would benefit most from analgesic interventions. 449 Infants with larger baseline nociceptive sensitivity had the greatest reduction in response 450 following the intervention. In contrast, infants with low baseline nociceptive sensitivity 451 were less likely to demonstrate a benefit of the intervention, as for this clinical procedure 452 the potential reduction in their responses was minimal. This could be due to a floor effect 453 whereby for some infants noxious-evoked brain responses to heel lance is close to zero and 454 cannot be reduced further. Improving our understanding of inter-individual variability in 455 pain responses is pivotal to ensure that for each individual infant potential adverse effects 456 of analgesics are carefully weighed against potential benefits. 457

458
In our final study, we demonstrate that paracetamol significantly reduced the magnitude of 459 the noxious-evoked brain activity following immunisation compared with infants who did CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review) preprint
The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint Paracetamol is administered as an antipyretic for the Meningitis B immunisations. An 493 update to our local clinical guidelines was implemented, whereby the paracetamol was 494 administered prior to rather than after immunisation. This meant we were able to 495 opportunistically study whether paracetamol can reduce noxious-evoked brain activity 496 following immunisation. Nevertheless, our study is significantly limited due to the 497 restricted sample sizes, lack of randomisation and blinding, and because in the Control 498 Group, where paracetamol was administered after immunisation, we did not record 499 baseline nociceptive sensitivity prior to immunisation. Therefore, we do not have data to 500 confirm that the baseline nociceptive sensitivity is correlated with the magnitude of the 501 evoked brain activity following immunisation; although, given there is no discernible 502 correlation between these measures in the Intervention Group, this strongly suggests that 503 this relationship has been disrupted by paracetamol administration. Furthermore, for 504 infants with high baseline nociceptive sensitivity, the brain responses evoked by the 505 immunisation were much lower than would be expected in the absence of the analgesic 506 intervention. To broaden the utility of this paradigm, it will be necessary to characterise 507 the correlation between baseline nociceptive sensitivity and a range of acute clinical 508 procedures, including immunisation. 509 510 Although many factors that influence individual variability in pain sensitivity in infants are 511 accounted for using the nociceptive sensitivity paradigm, it does not account for differences 512 in rapidly fluctuating trait effects such as differences in attention or sleep state that could 513 vary between the baseline sensitivity testing and the implementation of the clinical 514 procedure. Understanding how trait differences influence variability in pain responses will 515 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review) preprint
The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint facilitate better estimation of the expected responses to clinically-required painful 516 procedures. A recent fMRI study demonstrated that noxious-evoked brain activity can be 517 predicted from an infant's resting state brain activity as well as the structural integrity of 518 key white matter pathways (Baxter et al., n.d.). Investigating the role of baseline EEG 519 activity and exploring the neurological differences underlying variability in the pain-520 related brain activity described here could further improve the utility of the paradigm. 521 522 In summary, the assessment of pain in non-verbal infants is challenging  and 523 the wide variability in individual responses to painful procedures complicates the 524 assessment of analgesics. Currently there is a paucity of evidence regarding the efficacy of 525 pain-relieving interventions used in neonatal practice (Neville et al., 2014). Here, we 526 present a paradigm that accounts for individual nociceptive sensitivity and we demonstrate 527 its utility in terms of sample size reduction. Using this paradigm in clinical trials could 528 optimise resources, maximise the value of collected data and ultimately expedite the 529 discovery and validation of urgently needed analgesics for this patient population. 530 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review) preprint
The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint Methods 531 532 Study design and participants 533 534 A total of 99 infants were included in four studies. In Study 1, the relationship between 535 responses to experimental noxious stimuli and clinically-required heel lance was 536 investigated in nine infants using data previously collected for other (unpublished) studies. 537 In Study 2, the potential value of the statistical relationship identified in Study 1 was 538 investigated using computational simulations. In Study 3, brain activity and reflex 539 withdrawal responses from 40 infants were recorded to test the paradigm with gentle touch 540 as a pain-relief intervention. In Study 4 brain activity was recorded from 33 infants in 541 response to immunisations to test the analgesic efficacy of paracetamol. Additionally, the 542 brain-derived measures to characterise immunisation evoked activity were validated in a  Table 1. 551 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Research governance 552
Studies were conducted in accordance with the Declaration of Helsinki and Good Clinical 553 Practice guidelines. Ethical approval was obtained from the National Research Ethics 554 Service (reference 12/SC/0447) and informed written parental consent was obtained prior 555 to each study. 556 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Study 1. Characterising individual baseline nociceptive sensitivity using brain activity in 565
infants. 566

567
The aim of this study was to investigate the relationship between noxious-evoked brain 568 activity in response to experimental stimuli and clinically-required heel lance within-569 subjects in a group of term infants. We retrospectively searched all the data we had 570 previously collected (and that has not been previously published) to identify any term 571 infants who had received a clinically-required heel lance and experimental noxious stimuli 572 on the same test occasion. We identified 9 infants studied between 2014 and 2015 (age 573 range: 39 to 42 weeks' gestational age (GA)) who had all received experimental noxious 574 stimuli at a force of 64 mN. The magnitude of the noxious-evoked brain activity was 575 characterised by projecting a previously described template of noxious-evoked brain To investigate potential differences in the power achieved by accounting for individual 584 nociceptive sensitivity at different sample sizes (for a given effect size and significance 585 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint level) we simulated data sets. Each simulation consisted of a control group and an 586 intervention group. Given a sample size of N per group, we first simulated N individual 587 nociceptive sensitivity levels for each group by generating N uniform random numbers 588 within the range of expected sensitivities. The minimum expected sensitivity was set as the 589 minimum response to the experimental noxious stimuli in the data collected in Study 1, 590 and the maximum expected response was set from multiplying the maximum of data 591 The aim of this study was to test the nociceptive sensitivity paradigm using a gentle touch 629 intervention of known effect in reducing the noxious-evoked brain activity following a 630 clinically-required heel lance (Gursul et al., 2018). The sample size required was obtained 631 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint from the data simulated in Study 2. Assuming a 40% reduction in the magnitude of the 632 brain activity in the Intervention Group compared with the Control Group, a sample size 633 of 32 infants (16/group) would be sufficient to achieve a power of 95%, when an infant's 634 baseline nociceptive sensitivity is taken into account. A total of 40 infants aged 35 to 42 635 weeks PMA were prospectively recruited to the study. EEG and EMG activity were 636 recorded in response to experimental noxious stimuli (128 mN intensity) prior to a 637 clinically-required heel lance. The Intervention Group (n=22) received gentle touch at an 638 approximate rate of 3cm/s for 10 seconds before heel lancing and the Control Group the efficacy of gentle touch to reduce brain derived measures following a clinically-648 required heel lance (Gursul et al., 2018). The experimenter was cued to apply the brushing 649 velocity and noxious stimuli by following a computer visualisation coded using PsychoPy. 650 There was an inter-stimulus interval of approximately one second between the end of the 651 brush stimulation and the heel lance. 652 653 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint The magnitude of the noxious-evoked brain activity and the magnitude of the reflex 654 withdrawal were obtained for each individual trial. Each individual infants' nociceptive 655 sensitivity was calculated as the mean response to the experimental noxious stimulus. EEG 656 responses were rejected for gross movement artefacts. Following removal of infants whose 657 and EMG recordings using a contact trigger device (MRC Systems). 732 Hz. EEG was recorded from eight locations on the scalp (Cz, CPz, C3, C4, Oz, FCz, T3, 746 T4), with reference at Fz and ground at Fpz (forehead) according to the modified 747 international 10-20 system. Preparation gel (Nuprep gel, D.O. Weaver and Co.) was used 748 to gently clean the scalp with a cotton bud before disposable Ag/AgCl cup electrodes 749 (Ambu Neuroline) were placed with conductive paste (Elefix EEG paste, Nihon Kohden). 750 In Study 3, surface electromyography (EMG) was recorded from the limb ipsilateral to the 751 site of stimulation. Bipolar EMG electrodes (Ambu Neuroline 700 solid gel surface 752 electrodes) were placed on the bicep femoris muscle. 753 EEG signals were filtered from 0.5 -30Hz with a notch filter at 50 Hz. Epochs were 754 extracted 500 ms before the stimulus and 1000 ms after and were baseline corrected to the 755 account for this, responses were first Woody filtered within an infant to achieve maximum 769 correlation with the within-subject average. 770 EMG signals were filtered 10-500 Hz, with a notch filter at 50 Hz and harmonics, and 771 rectified. Epochs were extracted from 2s before to 4s after the stimulus. Individual epochs 772 were rejected due to movement artefact in the baseline period. The data was split into 250 773 ms windows and the root mean square (RMS) of the reflex signal was calculated in each 774 window. The average RMS across the first four windows after the stimulus (first second 775 after stimulation) was calculated as the magnitude of the reflex withdrawal. 776

Statistical analyses 777 778
parametrically via permutation testing with 10,000 permutations using PALM. The 792 difference between the intervention and control group in Study 4 was assessed using a 793 linear mixed effects model, with subject and number of immunisations set as random 794 effects. Two-sided tests were used for all statistical analysis with a significance level of 795 0.05. 796 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint     CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint development at school age. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.08.20246058 doi: medRxiv preprint